Unrelieved pain caused by cancer is experienced by more than 5 million people worldwide, and over the past 50 years has been accepted as unnecessary by both clinicians and politicians. Major innovations in the understanding ...

This transcript examines some of the major discoveries and developments in the management of leukaemia over the past 30 years, such as the discovery of the alkylating agents (chlorambucil and busulphan) at London’s Chester ...

In June 2000 a distinguished group of obstetricians, midwives, general practitioners, and medical statisticians came together to discuss maternal care. Chaired by Professor James Drife from Leeds, discussion ranged over ...

Cannabis has been considered as both an illicit drug and a medicine throughout its history. Introduced to the UK as a medicine in the nineteenth century, its medical utility was limited and it was not until tetrahydrocannabinol ...

Chaired by Professor Robert Boyd, this seminar reviewed the development and changes in care of the newborn in the UK over the past 50 years. Advances in techniques were described, such as mechanical ventilation, total ...

In May 2000, a distinguished group of scientists and clinicians came together in a one-day meeting to discuss the recent history of peptic ulcer, and its rise and fall. Chaired by Professor Roy Pounder from the Royal Free ...

The introduction of penicillin during the Second World War led to a revolution in both drug development and therapeutics. Several important themes emerged during the course of the meeting – the discovery of the antimicrobial ...

The 1974 reorganization of the National Health Service was largely seen as a disaster for the public health profession. The post of Medical Officer of Health, with its links to local government, was replaced by the community ...

As breast-milk substitutes became iAs breast-milk substitutes became increasingly sophisticated and heavily marketed in the mid-twentieth century, bottle-feeding became regarded worldwide as safe, convenient, normal and ...

The introduction in 1952 of isoniazid established the standard treatment of streptomycin, isoniazid and either thiacetazone or para-aminosalicylic acid for pulmonary tuberculosis. To achieve good results, patients had to ...